Can Challenge Prizes Transform Drug Discovery? w/ Tris Dyson

Subscribe to UnitedHealthcare's Community & State newsletter. Health Affairs' Rob Lott interviews Tris Dyson, Founder of Challenge Works on his efforts in cultivating challenge prizes as an opportunity to nurture innovation in science and health care, the newly launched Longitude Prize on ALS, the transformation of drug discovery, and more. Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast Subscribe to UnitedHealthcare's Community & State newsletter.